Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified antibiotic regimens for neonatal possible serious bacterial infection
ACTRN12610000286044Phase 3Not yet recruiting
- Sponsor
- World Health Organization
- Start
- Oct 2010
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of gentamicin, Benzathine penicillin and amoxicillin in Not applicable (no single disease) (5 arms), sponsored by World Health Organization. Primary endpoints: Treatment failure in stratum I and Treatment failure in stratum II. Planned start Oct 2010; status: not yet recruiting.
02
Drugs
gentamicinBenzathine penicillinamoxicillin
03
Conditions
Not applicable (no single disease)
Beyond the preview
Go deeper on ACTRN12610000286044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000286044.